434 related articles for article (PubMed ID: 36742318)
1. Programmed cell death and lipid metabolism of macrophages in NAFLD.
Xiao Z; Liu M; Yang F; Liu G; Liu J; Zhao W; Ma S; Duan Z
Front Immunol; 2023; 14():1118449. PubMed ID: 36742318
[TBL] [Abstract][Full Text] [Related]
2. Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease.
Govaere O; Petersen SK; Martinez-Lopez N; Wouters J; Van Haele M; Mancina RM; Jamialahmadi O; Bilkei-Gorzo O; Lassen PB; Darlay R; Peltier J; Palmer JM; Younes R; Tiniakos D; Aithal GP; Allison M; Vacca M; Göransson M; Berlinguer-Palmini R; Clark JE; Drinnan MJ; Yki-Järvinen H; Dufour JF; Ekstedt M; Francque S; Petta S; Bugianesi E; Schattenberg JM; Day CP; Cordell HJ; Topal B; Clément K; Romeo S; Ratziu V; Roskams T; Daly AK; Anstee QM; Trost M; Härtlova A
J Hepatol; 2022 May; 76(5):1001-1012. PubMed ID: 34942286
[TBL] [Abstract][Full Text] [Related]
3. Regulation of lipid-induced macrophage polarization through modulating peroxisome proliferator-activated receptor-gamma activity affects hepatic lipid metabolism via a Toll-like receptor 4/NF-κB signaling pathway.
Wu HM; Ni XX; Xu QY; Wang Q; Li XY; Hua J
J Gastroenterol Hepatol; 2020 Nov; 35(11):1998-2008. PubMed ID: 32128893
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic Changes in Macrophage Activation in a Model of Nonalcoholic Fatty Liver Disease using Microminipigs.
Yoshii D; Nakagawa T; Komohara Y; Kawaguchi H; Yamada S; Tanimoto A
J Atheroscler Thromb; 2021 Aug; 28(8):844-851. PubMed ID: 33012740
[TBL] [Abstract][Full Text] [Related]
5. Effect of modulation of PPAR-γ activity on Kupffer cells M1/M2 polarization in the development of non-alcoholic fatty liver disease.
Luo W; Xu Q; Wang Q; Wu H; Hua J
Sci Rep; 2017 Mar; 7():44612. PubMed ID: 28300213
[TBL] [Abstract][Full Text] [Related]
6. The Role of Tissue Macrophage-Mediated Inflammation on NAFLD Pathogenesis and Its Clinical Implications.
Alisi A; Carpino G; Oliveira FL; Panera N; Nobili V; Gaudio E
Mediators Inflamm; 2017; 2017():8162421. PubMed ID: 28115795
[TBL] [Abstract][Full Text] [Related]
7. Macrophages and scavenger receptors in obesity-associated non-alcoholic liver fatty disease (NAFLD).
Kragh Petersen S; Bilkei-Gorzo O; Govaere O; Härtlova A
Scand J Immunol; 2020 Nov; 92(5):e12971. PubMed ID: 32892401
[TBL] [Abstract][Full Text] [Related]
8. Natural products in non-alcoholic fatty liver disease (NAFLD): Novel lead discovery for drug development.
Wang L; Yan Y; Wu L; Peng J
Pharmacol Res; 2023 Oct; 196():106925. PubMed ID: 37714392
[TBL] [Abstract][Full Text] [Related]
9. Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease.
Rosso C; Kazankov K; Younes R; Esmaili S; Marietti M; Sacco M; Carli F; Gaggini M; Salomone F; Møller HJ; Abate ML; Vilstrup H; Gastaldelli A; George J; Grønbæk H; Bugianesi E
J Hepatol; 2019 Nov; 71(5):1012-1021. PubMed ID: 31301321
[TBL] [Abstract][Full Text] [Related]
10. Macrophage Function in the Pathogenesis of Non-alcoholic Fatty Liver Disease: The Mac Attack.
Oates JR; McKell MC; Moreno-Fernandez ME; Damen MSMA; Deepe GS; Qualls JE; Divanovic S
Front Immunol; 2019; 10():2893. PubMed ID: 31921154
[TBL] [Abstract][Full Text] [Related]
11. Glycyrrhetinic acid regulates impaired macrophage autophagic flux in the treatment of non-alcoholic fatty liver disease.
Fan Y; Dong W; Wang Y; Zhu S; Chai R; Xu Z; Zhang X; Yan Y; Yang L; Bian Y
Front Immunol; 2022; 13():959495. PubMed ID: 35967372
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiological mechanisms and therapeutic potentials of macrophages in non-alcoholic steatohepatitis.
Wu R; Nakatsu G; Zhang X; Yu J
Expert Opin Ther Targets; 2016; 20(5):615-26. PubMed ID: 26609894
[TBL] [Abstract][Full Text] [Related]
13. Hypericin attenuates nonalcoholic fatty liver disease and abnormal lipid metabolism via the PKA-mediated AMPK signaling pathway in vitro and in vivo.
Liang C; Li Y; Bai M; Huang Y; Yang H; Liu L; Wang S; Yu C; Song Z; Bao Y; Yi J; Sun L; Li Y
Pharmacol Res; 2020 Mar; 153():104657. PubMed ID: 31982488
[TBL] [Abstract][Full Text] [Related]
14. Liver macrophages and inflammation in physiology and physiopathology of non-alcoholic fatty liver disease.
Thibaut R; Gage MC; Pineda-Torra I; Chabrier G; Venteclef N; Alzaid F
FEBS J; 2022 Jun; 289(11):3024-3057. PubMed ID: 33860630
[TBL] [Abstract][Full Text] [Related]
15. Osr1 Regulates Macrophage-mediated Liver Inflammation in Nonalcoholic Fatty Liver Disease Progression.
Liu L; Zhou Y; Liu Z; Li J; Hu L; He L; Gao G; Kidd B; Walsh A; Jiang R; Wu C; Zhang K; Xie L
Cell Mol Gastroenterol Hepatol; 2023; 15(5):1117-1133. PubMed ID: 36581078
[TBL] [Abstract][Full Text] [Related]
16. Treating inflammation to combat non-alcoholic fatty liver disease.
Wiering L; Tacke F
J Endocrinol; 2023 Jan; 256(1):. PubMed ID: 36259984
[TBL] [Abstract][Full Text] [Related]
17. Kupffer Cells in Non-alcoholic Fatty Liver Disease: Friend or Foe?
Chen J; Deng X; Liu Y; Tan Q; Huang G; Che Q; Guo J; Su Z
Int J Biol Sci; 2020; 16(13):2367-2378. PubMed ID: 32760204
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of long non-coding RNA Gm10804 suppresses disorders of hepatic glucose and lipid metabolism in diabetes with non-alcoholic fatty liver disease.
Li T; Huang X; Yue Z; Meng L; Hu Y
Cell Biochem Funct; 2020 Oct; 38(7):839-846. PubMed ID: 32212193
[TBL] [Abstract][Full Text] [Related]
19. Alpinetin improved high fat diet-induced non-alcoholic fatty liver disease (NAFLD) through improving oxidative stress, inflammatory response and lipid metabolism.
Zhou Y; Ding YL; Zhang JL; Zhang P; Wang JQ; Li ZH
Biomed Pharmacother; 2018 Jan; 97():1397-1408. PubMed ID: 29156529
[TBL] [Abstract][Full Text] [Related]
20. Macrophage Activation in Pediatric Nonalcoholic Fatty Liver Disease (NAFLD) Correlates with Hepatic Progenitor Cell Response via Wnt3a Pathway.
Carpino G; Nobili V; Renzi A; De Stefanis C; Stronati L; Franchitto A; Alisi A; Onori P; De Vito R; Alpini G; Gaudio E
PLoS One; 2016; 11(6):e0157246. PubMed ID: 27310371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
